Zhengye Biotechnology Addresses Unusual Trading Activity

Zhengye Biotechnology Holding Limited issued a statement in response to recent unusual trading activity in its Class A ordinary shares. The company confirmed it is not aware of any material non-public information that would account for the increased trading activity, stating that business operations continue normally with no undisclosed corporate developments. Zhengye Biotechnology is cooperating with Nasdaq and other regulatory authorities and cautioned investors to rely on information in its SEC filings.